Yatharth Hospital Expects To Reach 5,000-Bed Capacity Sooner Than Three-Year Plan

Market snapshot: Yatharth Hospital has reported a stellar performance in Q1 FY27, with revenue growing 51.5% YoY to ₹392.65 cr, driven by strong growth in mature assets and rapid ramp-up of new acquisitions. During the earnings call, management highlighted that the company's aggressive bed expansion plan is on track, with the goal of reaching 5,000 beds potentially ahead of its original three-year timeline.

Data Snapshot

• Revenue from operations reached ₹392.65 cr, registering a growth of 51.5% YoY.
• EBITDA grew 39% YoY to ₹91.7 cr, with a consolidated EBITDA margin of 23.3%.
• Profit After Tax rose 8% YoY to ₹45.42 cr.

What's Changed

• Q1 FY27 Revenue of ₹392.65 cr vs ₹259.2 cr in Q1 FY26 (derived: ≈51.5% growth)
• EBITDA of ₹91.7 cr vs ₹66 cr in Q1 FY26 (derived: ≈39% growth)
• PAT of ₹45.42 cr vs ₹42.04 cr in Q1 FY26 (derived: ≈8% growth)
• EBITDA margin of 23.3% vs 25.4% in Q1 FY26 (derived: contraction of 209 bps)

Key Takeaways

• Aggressive bed expansion plan is targeting 5,000 beds, with management expecting to meet this target earlier than the scheduled three years.
• Newly acquired hospitals are scaling quickly, contributing ₹106.7 cr (27%) to total Q1 FY27 revenues.
• The newly integrated Faridabad Sector-20 hospital achieved EBITDA breakeven within a record nine months.
• The Model Town New Delhi hospital is ramping up, approaching an ARPOB of ₹50,000, with breakeven expected in H2 FY27.

SAHI Perspective

Yatharth Hospital's strategy of inorganic expansion is playing out exceptionally well, as shown by newly acquired assets ramping up to profitability much faster than expected. While the aggressive expansion has caused a temporary contraction of 209 bps in EBITDA margins to 23.3% due to initial operating losses, the underlying operational strength and strong balance sheet with a net cash of ₹116 cr ensure high financial viability for achieving the 5,000-bed milestone early.

Market Implications

The faster-than-planned bed expansion and quick turnaround of newly acquired hospitals are likely to drive strong revenue and EBITDA CAGR over the next few years. As new facilities mature and government business mix declines to the target 25% from 35%, margins should expand, leading to a potential re-rating of the stock. However, high employee costs, which rose 61.7% YoY, will need to be monitored.

Trading Signals

Market Bias: Bullish

Strong Q1 FY27 revenue growth of 51.5% YoY to ₹392.65 cr and rapid turnaround of new assets support a Bullish outlook. Management's guidance of achieving the 5,000-bed target ahead of schedule further solidifies long-term earnings visibility.

Overweight: Healthcare, Hospitals

Trigger Factors:

• Speed of EBITDA breakeven at Gurugram Sector-40 hospital expected by Q1 FY28
• Improvement in blended EBITDA margins back to 24-25% as newer hospitals mature
• Reduction of government scheme mix to under 30% to improve receivables

Time Horizon: Medium-term (3-12 months)

Industry Context

The Indian hospital sector is witnessing a strong wave of consolidation and inorganic expansion, as major players actively add beds via M&A. Yatharth Hospital's cluster-based approach in Delhi-NCR allows it to optimize costs and leverage brand recall. The company's focus on shifting its payer mix from government schemes (35%) to cash and private insurance is a trend seen across major chains to boost ARPOB and reduce working capital cycles.

Key Risks to Watch

• Staffing constraints and rise in employee expenses, which grew 61.7% YoY in Q1 FY27.
• Execution risks related to the integration and completion of under-construction facilities like Gurugram Sector-40.
• Slower-than-expected turnaround of newly operationalized beds impacting overall margins.

Recent Developments

In June 2026, Yatharth completed the acquisition and registration of a 250-bed under-construction hospital in Sector 40, Gurugram, for an upfront consideration of ₹100 cr. In May 2026, the company announced its FY26 results with a 36% YoY revenue growth. Additionally, on August 10, 2026, the Board approved its first-ever interim dividend of ₹0.50 per share (5% of face value) for FY27.

Closing Insight

Yatharth Hospital is executing a highly disciplined expansion playbook. By turning acquisitions profitable in record time and preparing to exceed its 5,000-bed target ahead of schedule, the company is positioning itself as a major healthcare powerhouse in North India.

High Performance Trading with SAHI.